Science
Ivermectin and Covid-19: what we still don’t know
At the moment there isn’t enough evidence to justify using the drug for the treatment or prevention of SARS-CoV-2
By Marc Mendelson, Francois Venter and Jeremy Nel
Science | 10 February 2021
Nearly all excess deaths are due to Covid-19
Lockdown restrictions are not responsible for massive increase in mortality
Science | 1 February 2021
Excess deaths decline for first time since November
Mortality still near record high but it looks like we are turning the corner
Science | 27 January 2021
Can you be reinfected with the new Covid-19 variant? And how effective will vaccines be against it?
We don’t know the answers yet, but a local study sheds some light
Science | 25 January 2021
Covid-19: Has the alcohol ban helped?
A study at Groote Schuur Hospital suggests it has freed up much-needed beds
Science | 19 January 2021
Will vaccines eradicate SARS-CoV-2?
Scientists predict the virus will be with us for the long-run - but as just another common cold
By James Stent
Science | 18 January 2021
Ivermectin and Covid-19: Why it’s promising but why we need to be cautious
While several studies have shown promising results there is not yet enough data for regulatory authorities to approve ivermectin
Science | 15 January 2021
Covid-19: Cell phone study shows where infections take place
“Stop pussyfooting around funerals” says infectious disease professor
Science | 14 January 2021
Record number of South Africans died in first week of 2021
11,000 of the nearly 20,000 deaths are considered excess deaths. The vast majority are likely due to Covid-19
By James Stent and Nathan Geffen
Science | 13 January 2021